XML 13 R2.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Jul. 02, 2017
Dec. 31, 2016
Current assets:    
Cash $ 14,933 $ 10,629
Restricted cash 83 77
Trade accounts receivable, net of allowance for doubtful accounts of $273 and $277, respectively 13,543 13,179
Inventories, net 24,490 23,456
Prepaid expenses and other current assets 1,754 2,079
Total current assets 54,803 49,420
Property, equipment and improvements, net 7,833 7,999
Goodwill 20,223 19,965
Intangible assets, net 7,169 7,194
Security deposits and other non-current assets 143 72
Deferred income taxes 94 94
Total assets 90,265 84,744
Current liabilities:    
Accounts payable 7,647 7,292
Accrued compensation and related benefits 1,875 1,258
Accrued expenses and other current liabilities 1,966 2,606
Income taxes payable 386 172
Total current liabilities 11,874 11,328
Deferred income taxes 5,615 5,538
Other non-current liabilities 27 18
Total liabilities 17,516 16,884
Commitments and contingencies (Note 11)
Shareholders' equity:    
Preferred stock – par value $.10 per share; authorized 1,000,000 shares; none issued
Common stock – par value $.10 per share; authorized 40,000,000 shares; issued – 19,567,642 shares at July 2, 2017 and 19,324,723 shares at December 31, 2016; outstanding – 15,551,890 shares at July 2, 2017 and 15,308,971 at December 31, 2016 1,957 1,932
Capital in excess of par value 179,519 178,163
Accumulated deficit (87,793) (90,542)
Accumulated other comprehensive loss (2,327) (3,080)
Treasury stock - at cost; 4,015,752 shares (18,443) (18,443)
Total Ultralife Corporation equity 72,913 68,030
Non-controlling interest (164) (170)
Total shareholders’ equity 72,749 67,860
Total liabilities and shareholders' equity $ 90,265 $ 84,744